Category: Press Releases

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for future milestone-dependent payments and royalties, while retaining rights to commercialize CV-01 in the Republic of […]

Reconnu pour l’exhaustivité globale de sa vision du marché et sa capacité d’exécution BOSTON, 18 oct. 2024 (GLOBE NEWSWIRE) — Duck Creek Technologies, l’un des principaux fournisseurs de solutions novatrices sur le marché des plateformes centrales SaaS d’assurances multirisques, a annoncé aujourd’hui que Duck Creek Technologies a été classé en tant que Leader par Gartner […]